Publications by authors named "Alexander Prouty"

Claim this Profile
P
PRMT5 inhibition drives therapeutic vulnerability to combination treatment with BCL-2 inhibition in mantle cell lymphoma.
Fiona Brown-Burke, Inah Hwang, Shelby Sloan, Claire Hinterschied, JoBeth Helmig-Mason, Alexander Prouty

Blood Adv· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRMT5 supports multiple oncogenic pathways in mantle cell lymphoma.
Shelby L Sloan, Fiona Brown, Mackenzie Long, Christoph Weigel, Shirsha Koirala, Alexander Prouty

Blood· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A sumoylation program is essential for maintaining the mitotic fidelity in proliferating mantle cell lymphoma cells.
Walter Hanel, Pushpa Lata, Youssef Youssef, Ha Tran, Liudmyla Tsyba, Alexander Prouty

Exp Hematol Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transducin β-like protein 1 controls multiple oncogenic networks in diffuse large B-cell lymphoma.
Youssef Youssef, Vrajesh Karkhanis, Wing Keung Chan, Frankie Jeney, Alessandro Canella, Alexander Prouty

Haematologica· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Delivery of BZLF1 to DEC205 Drives EBV-Protective Immunity in a Spontaneous Model of EBV-Driven Lymphoproliferative Disease.
Elshafa Hassan Ahmed, Eric Brooks, Shelby Sloan, Sarah Schlotter, Frankie Jeney, Alexander Prouty

Vaccines (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of the Hsp90 inhibitor SNX-5422 in ibrutinib resistant CLL.
Timothy L Chen, Bonnie Harrington, Jean Truxall, Ronni Wasmuth, Alexander Prouty

J Hematol Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis